This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Encephalitis  • Radiologic Imaging  • Magnetic Resonance Imaging  • PET/ SPECT Imaging  • Alert me on articles by topic  Social Bookmarking   What's this?

Rainer Scheid, MD; Thomas Lincke, MD; Raymond Voltz, MD, PhD; D. Yves von Cramon, MD, PhD; Osama Sabri, MD, PhD

Arch Neurol. 2004;61:1785-1789.

Objectives  To review and expand the existing literature of magnetic resonance imaging (MRI) and positron emission tomography (PET) of paraneoplastic limbic encephalitis (PLE).

Methods  We performed serial MRI and ¹⁸F-fluoro-2-deoxy-D-glucose (FDG)–PET in a patient with anti-Ma2–positive PLE. In addition, we reviewed the relevant literature by conducting a search in the MEDLINE database.

Results  We found a total of 7 published patient studies of possible or probable PLE containing both MRI and PET data. In 1 of these reports, the diagnosis of PLE can be regarded as proven. The results of the previous studies are controversial. Epileptic activity and inflammation are assumed to be underlying mechanisms of increased FDG uptake. In our study, we found a focal tracer accumulation in the left medial temporal lobe, which increased during the first 9 months of follow-up and corresponded with an increase of serum anti-Ma2 antibody titers. The MRI findings showed a hyperintense signal change in the left medial temporal lobe without contrast enhancement, which remained unchanged over time.

Conclusions  The results of functional and structural imaging in PLE may differ substantially. Results of FDG-PET can demonstrate focal hypermetabolism over a long time, which may indicate therapeutic potential. A prospective study with more patients will be needed to clarify the relevance of PET as a possible outcome measure in PLE. Future studies should include scalp or semi-invasive electroencephalographic recordings during PET acquisition.

Author Affiliations: Day Clinic of Cognitive Neurology (Drs Scheid and von Cramon) and Department of Nuclear Medicine (Drs Lincke and Sabri), University of Leipzig, and Max-Planck Institute for Human Cognitive and Brain Sciences (Drs Scheid and von Cramon), Leipzig, Germany; and Institute of Clinical Neuroimmunology, University of Munich, Munich, Germany (Dr Voltz).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cerebral glucose metabolism in Fisher syndrome
Kim et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:512-517.
ABSTRACT | FULL TEXT  

Primary Renal Lymphoma Presenting With Paraneoplastic Limbic Encephalitis
Rajappa et al.
JCO 2007;25:3783-3785.
FULL TEXT  

Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration
Choi et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:525-528.
ABSTRACT | FULL TEXT  

Anti-Ma2 associated paraneoplastic neurological syndrome presenting as encephalitis and progressive muscular atrophy
Waragai et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:111-113.
ABSTRACT | FULL TEXT  

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances et al.
Brain 2005;128:1764-1777.
ABSTRACT | FULL TEXT